This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Good morning. The Boston Marathon is today, and I’m feeling particularly inspired by this runner who went from being partially paralyzed to running in this year’s race. Stock futures are falling this morning. The three major indexes are coming off a winning…
Wegovy semaglutide tablets. Michael Siluk | Universal Images Group | Getty Images The Wegovy pill showed more pronounced weight loss and less cumbersome side effects than Eli Lilly‘s rival pill that was approved this week, Novo Nordisk said Thursday. Oral Wegovy demonstrated “significantly greater mean weight loss” than orforglipron, which Lilly will sell under the…
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Friday. If you’re as fascinated by the retail sector as I am, you’ll want to read this exclusive from CNBC’s Melissa Repko. I don’t want to spoil it, so I’ll just say that Target isn’t over its boycott woes. Stock futures…